Critical Review: LifeStance Health Group (NASDAQ:LFST) & Ceres Ventures (OTCMKTS:CEVE)

LifeStance Health Group (NASDAQ:LFST) and Ceres Ventures (OTCMKTS:CEVE) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation.

Risk & Volatility

LifeStance Health Group has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Ceres Ventures has a beta of 2.27, indicating that its stock price is 127% more volatile than the S&P 500.

Valuation and Earnings

This table compares LifeStance Health Group and Ceres Ventures”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.25 billion	1.70	-$57.44 million	($0.05)	-109.60
Ceres Ventures	N/A	N/A	N/A	N/A	N/A

Ceres Ventures has lower revenue, but higher earnings than LifeStance Health Group.

Profitability

This table compares LifeStance Health Group and Ceres Ventures’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	-1.23%	-1.11%	-0.76%
Ceres Ventures	N/A	N/A	N/A

Insider & Institutional Ownership

85.5% of LifeStance Health Group shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by company insiders. Comparatively, 0.1% of Ceres Ventures shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and price targets for LifeStance Health Group and Ceres Ventures, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	1	0	5	1	2.86
Ceres Ventures	0	0	0	0	0.00

LifeStance Health Group currently has a consensus target price of $8.50, suggesting a potential upside of 55.11%. Given LifeStance Health Group’s stronger consensus rating and higher possible upside, research analysts clearly believe LifeStance Health Group is more favorable than Ceres Ventures.

Summary

LifeStance Health Group beats Ceres Ventures on 7 of the 11 factors compared between the two stocks.

About LifeStance Health Group

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

About Ceres Ventures

Ceres Ventures, Inc., a development stage company, focuses on the research, development, and commercialization of clean technologies for the remediation of polluted water, soil, and air. Its technologies include BluFlow Nanoparticles, a proprietary system for formulating, producing, and deploying customizable absorbent nanoparticles to specific functionality for contaminant/chemical removal and extraction of valuable elements and compounds from water based solutions; BluFlow Advanced Ultrafiltration Technology, an automated process to recover water from waste or impure streams; and BluFlow Treatment System a water and wastewater treatment solution, which incorporates the BluFlow Nanoparticles and the BluFlow Advanced Ultrafiltration Technology to remove target elements, compounds, and pollutants, as well as purify water that may be suitable for reuse. Ceres Ventures, Inc.'s products are used in water and wastewater treatment and purification, contaminated groundwater treatment, industrial wastewater treatment, and valuable elements and compounds extraction applications. The company was formerly known as PhytoMedical Technologies, Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was founded in 2010 and is based in New York, New York.